Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Lupus|April 1, 2010
Antiphospholipid syndrome: critical analysis of the diagnostic pathV Pengo, A Banzato, E Bison, et al.
Lupus|October 16, 2015
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trialV Pengo, A Banzato, E Bison, et al.
European Journal of Internal Medicine|March 27, 2013
Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: a population-based studyR Joppi, E Cinconze, L Mezzalira, et al.
Minerva Cardioangiologica|October 1, 1986
[Prevention of deep venous thrombosis with low-dose heparin in patients with acute uncomplicated myocardial infarct: double-blind controlled study]P Prandoni, R Russo, V Pengo, et al.
Thrombosis and Haemostasis|February 24, 2001
Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteinsP Rampazzo, A Biasiolo, J Garin, et al.
Minerva Medica|July 31, 1987
[Study of blood platelet activation in migraine in childhood]P A Battistella, M Cavinato, P Cogo, et al.
Autoimmunity Reviews|December 11, 2012
Correct laboratory approach to APS diagnosis and monitoringV Pengo, A Banzato, G Denas, et al.
Lupus|November 9, 2019
An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)E Pontara, C Cheng, M G Cattini, et al.
European Journal of Clinical Investigation|April 1, 1989
The optimal therapeutic range for oral anticoagulant treatment as suggested by fibrinopeptide A (FpA) levels in patients with heart valve prosthesesV Pengo, P Peruzzi, M Baca, et al.
Journal of Medicine|January 1, 1984
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancerV Pengo, S Levi Minzi, R Dal Bo Zanon, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Lupus|April 1, 2010
Antiphospholipid syndrome: critical analysis of the diagnostic pathV Pengo, A Banzato, E Bison, et al.
Lupus|October 16, 2015
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trialV Pengo, A Banzato, E Bison, et al.
European Journal of Internal Medicine|March 27, 2013
Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: a population-based studyR Joppi, E Cinconze, L Mezzalira, et al.
Minerva Cardioangiologica|October 1, 1986
[Prevention of deep venous thrombosis with low-dose heparin in patients with acute uncomplicated myocardial infarct: double-blind controlled study]P Prandoni, R Russo, V Pengo, et al.
Thrombosis and Haemostasis|February 24, 2001
Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteinsP Rampazzo, A Biasiolo, J Garin, et al.
Minerva Medica|July 31, 1987
[Study of blood platelet activation in migraine in childhood]P A Battistella, M Cavinato, P Cogo, et al.
Autoimmunity Reviews|December 11, 2012
Correct laboratory approach to APS diagnosis and monitoringV Pengo, A Banzato, G Denas, et al.
Lupus|November 9, 2019
An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)E Pontara, C Cheng, M G Cattini, et al.
European Journal of Clinical Investigation|April 1, 1989
The optimal therapeutic range for oral anticoagulant treatment as suggested by fibrinopeptide A (FpA) levels in patients with heart valve prosthesesV Pengo, P Peruzzi, M Baca, et al.
Journal of Medicine|January 1, 1984
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancerV Pengo, S Levi Minzi, R Dal Bo Zanon, et al.
Pageof 17